Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab
Clinical trial NCT00636805 · TERMINATED
Trial details
- NCT number
- NCT00636805
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.